• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Natco Pharma Limited — Updates, 14-02-2026: Press Release

    14-02-2026 | 09:31 am

    NATCO Pharma has received approval to manufacture and market generic Semaglutide Injection in India. This product, for type 2 diabetes treatment, will launch in the Indian market soon, expanding NATCO's portfolio.

    No comments yet. Be the first to comment!

    All announcements from Natco Pharma Limited